Back

Is gender important is patients with decompensated heart failure and valvular disease?

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - epidemiology, prognosis, outcome 5 Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Associate Professor Adina Pop-Moldovan

Arad County Emergency Clinical Hospital, Arad (Romania)

7 More presentations in this session

Presentation thumbnail
Comprehensive characterization of patients with heart failure and recovered ejection fraction: insights from a real-world population from a regional hospital in Portugal
Doctor A. Fonseca Vazao (Leiria, PT)
Abstract Slides Video
Presentation thumbnail
The prognostic role of mean platelet volume in chronic decompensated heart failure.
Miss A. Catana (Bucharest, RO)
Abstract Slides Video
Presentation thumbnail
Predictors of quality of life in heart failure patients
Doctor K. Bince (Pristina, XK)
Abstract Slides Video
Presentation thumbnail
The incidence of severe heart failure among hospitalized patients with HFrEF. Do we have a simplified diagnostic criteria helping in the earlier diagnosis and better prognosis?
Doctor F. Banfi-Bacsardi (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Prevalence and incidence of dilated cardiomyopathy in the United States, France, Germany, Italy, Spain, and the United Kingdom: a systematic literature review
Doctor A. Berge (Canonsburg, US)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - epidemiology, prognosis, outcome 5

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Use of guideline-directed medical therapy in women hospitalised for decompensated heart failure
thumbnail
Congress Presentation
Sex influence on heart failure
thumbnail
Congress Presentation
Gender differences in clinical profiles, management, and outcomes of valvular heart disease: insights from a nationwide cohort

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources